Seguir
Salil Desai
Salil Desai
Dirección de correo verificada de novartis.com
Título
Citado por
Citado por
Año
The stabilizing effect of moisture on the solid-state degradation of gabapentin
Z Zong, SD Desai, AM Kaushal, DH Barich, HS Huang, EJ Munson, ...
AAPS PharmSciTech 12, 924-931, 2011
452011
Investigating gabapentin polymorphism using solid-state NMR spectroscopy
KE Dempah, DH Barich, AM Kaushal, Z Zong, SD Desai, ...
Aaps Pharmscitech 14, 19-28, 2013
392013
Design, synthesis, and pharmacokinetic evaluation of phosphate and amino acid ester prodrugs for improving the oral bioavailability of the HIV-1 protease inhibitor atazanavir
M AM Subbaiah, S Mandlekar, S Desikan, T Ramar, L Subramani, ...
Journal of Medicinal Chemistry 62 (7), 3553-3574, 2019
262019
Discovery of BMS-986144, a third-generation, pan-genotype NS3/4A protease inhibitor for the treatment of hepatitis C virus infection
LQ Sun, E Mull, S D’Andrea, B Zheng, S Hiebert, E Gillis, M Bowsher, ...
Journal of Medicinal Chemistry 63 (23), 14740-14760, 2020
122020
Coupling of an acyl migration prodrug strategy with bio-activation to improve oral delivery of the HIV-1 protease inhibitor atazanavir
MAM Subbaiah, NA Meanwell, JF Kadow, L Subramani, M Annadurai, ...
Journal of Medicinal Chemistry 61 (9), 4176-4188, 2018
122018
The ortho effect on the acidic and alkaline hydrolysis of substituted formanilides
SD Desai, LE Kirsch
International Journal of Chemical Kinetics 47 (8), 471-488, 2015
112015
Cross-linking of poly (vinyl alcohol) films under acidic and thermal stress
SD Desai, I Kundu, NP Swamy, GB Crull, D Pan, J Zhao, RP Shah, ...
European Journal of Pharmaceutical Sciences 152, 105429, 2020
82020
(Carbonyl) oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration
MAM Subbaiah, T Ramar, L Subramani, SD Desai, S Sinha, S Mandlekar, ...
European Journal of Medicinal Chemistry 207, 112749, 2020
62020
Discovery of a second generation, pan genotype NS3/4A protease inhibitor (BMS-986144) for the treatment of hepatitis C
P Scola, LQ Sun, E Gillis, M Bowsher, J Chen, X Wang, SY Sit, Y Chen, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
22015
Improving Drug Delivery While Tailoring Prodrug Activation to Modulate Cmax and Cmin by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of …
M AM Subbaiah, L Subramani, T Ramar, S Desai, S Sinha, S Mandlekar, ...
Journal of Medicinal Chemistry 65 (16), 11150-11176, 2022
12022
Ortho substitution effects on the acidic and alkaline hydrolyses of formanilides
SD Desai
The University of Iowa, 2009
12009
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions
J Chu, E Panfen, L Wang, A Marino, XQ Chen, RM Fancher, R Landage, ...
Pharmaceutical Research 40 (11), 2567-2584, 2023
2023
Discovery of BMS-986160 as a second-generation inhibitor of the hepatitis C virus NS3/4A with pan-genotypic antiviral activity
LQ Sun, E Mull, S Kandhasamy, VR Baratam, S Puttaswamy, N Pulicharla, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
Second-generation inhibitors of the hepatitis C virus NS3/4A protease: Discovery of BMS-986144 with pan-genotypic antiviral activity
LQ Sun, E Mull, Q Zhao, E Gillis, M Bowsher, S D'Andrea, Z Zheng, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017
2017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–14